The Scientist

» drug development, immunology and ecology

Most Recent

image: Speaking of Science

Speaking of Science

By | October 1, 2013

October 2013's selection of notable quotes

0 Comments

image: Influential Ecologist Dies

Influential Ecologist Dies

By | September 24, 2013

Ruth Patrick, who pioneered freshwater pollution monitoring, has passed away at age 105.

1 Comment

image: Opinion: Reasons for the R&D Crisis

Opinion: Reasons for the R&D Crisis

By | September 23, 2013

Response to an opinion in The Scientist charting current pitfalls in translational research

2 Comments

image: Opinion: Sexual Dysfunction Matters

Opinion: Sexual Dysfunction Matters

By | August 19, 2013

Desire and arousal disorders require the biopharmaceutical industry’s attention.

7 Comments

image: Dolphins by Name

Dolphins by Name

By | July 23, 2013

Bottlenose dolphins can recognize and respond to their own “signature whistles,” strengthening the evidence that these whistles function like names.

2 Comments

image: Week in Review, July 15–19

Week in Review, July 15–19

By | July 19, 2013

Bias in preclinical research; medical marijuana for kids; a swath of microbial genomes; plastic ocean habitats; rethinking scientific evaluation

0 Comments

image: Cancer Gene Data Released

Cancer Gene Data Released

By | July 18, 2013

NCI has made public the largest-ever database of cancer-specific gene variations, paving the way for the development of new drugs and therapies.

0 Comments

image: Medical Marijuana for Kids?

Medical Marijuana for Kids?

By | July 17, 2013

The drug has brought relief to children suffering from cancer and other serious ailments, but getting access is often limited by considerable regulatory hurdles.

6 Comments

image: Week in Review, July 8–12

Week in Review, July 8–12

By | July 12, 2013

Editor accused of fraud leaves post; the good and the bad of gut microbiota; bacterial gene shuffle; legal restrictions hamper illicit drug research; antibodies and autism

0 Comments

image: Misconduct Delayed Drug Approval

Misconduct Delayed Drug Approval

By | July 10, 2013

FDA endorsement of a new blood-thinning drug was held back for almost a year because the agency discovered misconduct at clinical trial sites in China.  

2 Comments

Popular Now

  1. Top 10 Innovations 2016
    Features Top 10 Innovations 2016

    This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

  2. Gut Microbes Linked to Neurodegenerative Disease
  3. Pubic Hair Grooming Linked to STI Risk
    The Nutshell Pubic Hair Grooming Linked to STI Risk

    Observational study suggests pubic hair grooming correlates with heightened risk of acquiring sexually transmitted infections, although causation remains unclear.

  4. Naive T Cells Find Homes in Lymphoid Tissue
Rockland